nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—PTGS1—breast cancer	0.158	0.483	CbGaD
Ketamine—CYP3A4—breast cancer	0.0923	0.282	CbGaD
Ketamine—ABCB1—breast cancer	0.0769	0.235	CbGaD
Ketamine—CYP2B6—Thiotepa—breast cancer	0.0336	0.0738	CbGbCtD
Ketamine—CYP2C9—Anastrozole—breast cancer	0.0234	0.0515	CbGbCtD
Ketamine—CYP2B6—Raloxifene—breast cancer	0.0224	0.0493	CbGbCtD
Ketamine—CYP2C8—Lapatinib—breast cancer	0.0224	0.0492	CbGbCtD
Ketamine—ABCB1—Toremifene—breast cancer	0.0208	0.0457	CbGbCtD
Ketamine—CYP3A4—Exemestane—breast cancer	0.018	0.0395	CbGbCtD
Ketamine—CYP2C9—Idarubicin—breast cancer	0.0178	0.039	CbGbCtD
Ketamine—CYP2C8—Raloxifene—breast cancer	0.017	0.0373	CbGbCtD
Ketamine—CYP3A4—Letrozole—breast cancer	0.0153	0.0336	CbGbCtD
Ketamine—ABCB1—Lapatinib—breast cancer	0.0152	0.0333	CbGbCtD
Ketamine—CYP2B6—Tamoxifen—breast cancer	0.0148	0.0325	CbGbCtD
Ketamine—CYP3A4—Anastrozole—breast cancer	0.0136	0.0299	CbGbCtD
Ketamine—CYP3A4—Toremifene—breast cancer	0.0125	0.0274	CbGbCtD
Ketamine—CYP3A4—Fulvestrant—breast cancer	0.0116	0.0254	CbGbCtD
Ketamine—CYP2B6—Irinotecan—breast cancer	0.0114	0.025	CbGbCtD
Ketamine—CYP2C8—Tamoxifen—breast cancer	0.0112	0.0246	CbGbCtD
Ketamine—CYP3A4—Thiotepa—breast cancer	0.0103	0.0227	CbGbCtD
Ketamine—CYP2C9—Capecitabine—breast cancer	0.00973	0.0214	CbGbCtD
Ketamine—CYP3A4—Ixabepilone—breast cancer	0.00945	0.0207	CbGbCtD
Ketamine—CYP3A4—Lapatinib—breast cancer	0.0091	0.02	CbGbCtD
Ketamine—CYP2C8—Paclitaxel—breast cancer	0.00874	0.0192	CbGbCtD
Ketamine—ABCB1—Vinorelbine—breast cancer	0.00842	0.0185	CbGbCtD
Ketamine—CYP2C8—Fluorouracil—breast cancer	0.00828	0.0182	CbGbCtD
Ketamine—CYP2C9—Tamoxifen—breast cancer	0.00783	0.0172	CbGbCtD
Ketamine—ABCB1—Tamoxifen—breast cancer	0.0076	0.0167	CbGbCtD
Ketamine—ABCB1—Mitoxantrone—breast cancer	0.00741	0.0163	CbGbCtD
Ketamine—CYP3A4—Raloxifene—breast cancer	0.00689	0.0151	CbGbCtD
Ketamine—ABCB1—Gemcitabine—breast cancer	0.00655	0.0144	CbGbCtD
Ketamine—CYP2B6—Doxorubicin—breast cancer	0.00622	0.0137	CbGbCtD
Ketamine—CYP2C9—Paclitaxel—breast cancer	0.0061	0.0134	CbGbCtD
Ketamine—ABCB1—Paclitaxel—breast cancer	0.00592	0.013	CbGbCtD
Ketamine—ABCB1—Irinotecan—breast cancer	0.00584	0.0128	CbGbCtD
Ketamine—CYP2C9—Fluorouracil—breast cancer	0.00577	0.0127	CbGbCtD
Ketamine—ABCB1—Vinblastine—breast cancer	0.00519	0.0114	CbGbCtD
Ketamine—CYP3A4—Vinorelbine—breast cancer	0.00505	0.0111	CbGbCtD
Ketamine—CYP3A4—Tamoxifen—breast cancer	0.00455	0.01	CbGbCtD
Ketamine—CYP3A4—Mitoxantrone—breast cancer	0.00444	0.00975	CbGbCtD
Ketamine—ABCB1—Docetaxel—breast cancer	0.00428	0.00939	CbGbCtD
Ketamine—CYP3A4—Paclitaxel—breast cancer	0.00354	0.00778	CbGbCtD
Ketamine—CYP3A4—Irinotecan—breast cancer	0.0035	0.00768	CbGbCtD
Ketamine—ABCB1—Doxorubicin—breast cancer	0.00319	0.007	CbGbCtD
Ketamine—CYP3A4—Vinblastine—breast cancer	0.00311	0.00682	CbGbCtD
Ketamine—ABCB1—Methotrexate—breast cancer	0.00309	0.00678	CbGbCtD
Ketamine—CYP3A4—Docetaxel—breast cancer	0.00256	0.00563	CbGbCtD
Ketamine—CYP3A4—Doxorubicin—breast cancer	0.00191	0.00419	CbGbCtD
Ketamine—TACR1—adipose tissue—breast cancer	0.00049	0.0493	CbGeAlD
Ketamine—TACR1—female reproductive system—breast cancer	0.00045	0.0453	CbGeAlD
Ketamine—TACR1—adrenal gland—breast cancer	0.000439	0.0442	CbGeAlD
Ketamine—GRIN1—endocrine gland—breast cancer	0.000417	0.0419	CbGeAlD
Ketamine—GRIN2A—adrenal gland—breast cancer	0.000401	0.0403	CbGeAlD
Ketamine—GRIN2B—endocrine gland—breast cancer	0.000397	0.04	CbGeAlD
Ketamine—TACR1—endocrine gland—breast cancer	0.000381	0.0383	CbGeAlD
Ketamine—CYP2C8—mammary gland—breast cancer	0.000363	0.0365	CbGeAlD
Ketamine—Nausea—Lapatinib—breast cancer	0.00036	0.0041	CcSEcCtD
Ketamine—Decreased appetite—Idarubicin—breast cancer	0.000355	0.00404	CcSEcCtD
Ketamine—Vomiting—Fulvestrant—breast cancer	0.000354	0.00403	CcSEcCtD
Ketamine—Arrhythmia—Goserelin—breast cancer	0.000354	0.00402	CcSEcCtD
Ketamine—Nystagmus—Doxorubicin—breast cancer	0.000352	0.004	CcSEcCtD
Ketamine—Rash—Fulvestrant—breast cancer	0.000351	0.004	CcSEcCtD
Ketamine—Dermatitis—Fulvestrant—breast cancer	0.000351	0.004	CcSEcCtD
Ketamine—Convulsion—Chlorambucil—breast cancer	0.000351	0.004	CcSEcCtD
Ketamine—OPRK1—female reproductive system—breast cancer	0.000351	0.0353	CbGeAlD
Ketamine—Vomiting—Toremifene—breast cancer	0.00035	0.00398	CcSEcCtD
Ketamine—Pain—Raloxifene—breast cancer	0.000349	0.00397	CcSEcCtD
Ketamine—GRIN2A—endocrine gland—breast cancer	0.000347	0.0349	CbGeAlD
Ketamine—Rash—Toremifene—breast cancer	0.000347	0.00395	CcSEcCtD
Ketamine—Dermatitis—Toremifene—breast cancer	0.000347	0.00394	CcSEcCtD
Ketamine—Erythema—Goserelin—breast cancer	0.000345	0.00392	CcSEcCtD
Ketamine—Apnoea—Methotrexate—breast cancer	0.000342	0.00389	CcSEcCtD
Ketamine—Nausea—Fulvestrant—breast cancer	0.000331	0.00377	CcSEcCtD
Ketamine—Nausea—Toremifene—breast cancer	0.000327	0.00372	CcSEcCtD
Ketamine—Vision blurred—Goserelin—breast cancer	0.000325	0.0037	CcSEcCtD
Ketamine—CYP2C9—mammary gland—breast cancer	0.000322	0.0324	CbGeAlD
Ketamine—Convulsion—Vinblastine—breast cancer	0.000322	0.00366	CcSEcCtD
Ketamine—Arrhythmia—Vinorelbine—breast cancer	0.000317	0.0036	CcSEcCtD
Ketamine—Anorexia—Chlorambucil—breast cancer	0.000315	0.00359	CcSEcCtD
Ketamine—Erythema—Vinorelbine—breast cancer	0.000309	0.00351	CcSEcCtD
Ketamine—Vomiting—Exemestane—breast cancer	0.000308	0.0035	CcSEcCtD
Ketamine—Convulsion—Melphalan—breast cancer	0.000306	0.00348	CcSEcCtD
Ketamine—Rash—Exemestane—breast cancer	0.000305	0.00347	CcSEcCtD
Ketamine—Dermatitis—Exemestane—breast cancer	0.000305	0.00347	CcSEcCtD
Ketamine—Arrhythmia—Thiotepa—breast cancer	0.000302	0.00344	CcSEcCtD
Ketamine—Convulsion—Goserelin—breast cancer	0.000299	0.0034	CcSEcCtD
Ketamine—Bradycardia—Mitoxantrone—breast cancer	0.000298	0.00339	CcSEcCtD
Ketamine—Bradycardia—Irinotecan—breast cancer	0.000298	0.00339	CcSEcCtD
Ketamine—Erythema—Thiotepa—breast cancer	0.000295	0.00335	CcSEcCtD
Ketamine—Vomiting—Ixabepilone—breast cancer	0.00029	0.00331	CcSEcCtD
Ketamine—Anorexia—Vinblastine—breast cancer	0.000289	0.00329	CcSEcCtD
Ketamine—Anaphylactic shock—Melphalan—breast cancer	0.000288	0.00328	CcSEcCtD
Ketamine—Rash—Ixabepilone—breast cancer	0.000288	0.00328	CcSEcCtD
Ketamine—Dermatitis—Ixabepilone—breast cancer	0.000288	0.00328	CcSEcCtD
Ketamine—Nausea—Exemestane—breast cancer	0.000288	0.00327	CcSEcCtD
Ketamine—Decreased appetite—Chlorambucil—breast cancer	0.000287	0.00327	CcSEcCtD
Ketamine—Cystitis noninfective—Methotrexate—breast cancer	0.000283	0.00322	CcSEcCtD
Ketamine—Diplopia—Capecitabine—breast cancer	0.000283	0.00322	CcSEcCtD
Ketamine—Pain—Chlorambucil—breast cancer	0.000283	0.00322	CcSEcCtD
Ketamine—Anaphylactic shock—Goserelin—breast cancer	0.000281	0.0032	CcSEcCtD
Ketamine—Anorexia—Tamoxifen—breast cancer	0.000281	0.00319	CcSEcCtD
Ketamine—Cystitis—Methotrexate—breast cancer	0.00028	0.00319	CcSEcCtD
Ketamine—Vision blurred—Thiotepa—breast cancer	0.000278	0.00316	CcSEcCtD
Ketamine—Shock—Goserelin—breast cancer	0.000277	0.00315	CcSEcCtD
Ketamine—Anorexia—Melphalan—breast cancer	0.000275	0.00313	CcSEcCtD
Ketamine—Vomiting—Anastrozole—breast cancer	0.000274	0.00311	CcSEcCtD
Ketamine—Vomiting—Letrozole—breast cancer	0.000274	0.00311	CcSEcCtD
Ketamine—Nausea—Ixabepilone—breast cancer	0.000271	0.00309	CcSEcCtD
Ketamine—Rash—Letrozole—breast cancer	0.000271	0.00309	CcSEcCtD
Ketamine—Rash—Anastrozole—breast cancer	0.000271	0.00309	CcSEcCtD
Ketamine—Dermatitis—Letrozole—breast cancer	0.000271	0.00308	CcSEcCtD
Ketamine—Dermatitis—Anastrozole—breast cancer	0.000271	0.00308	CcSEcCtD
Ketamine—Hypotension—Melphalan—breast cancer	0.000269	0.00307	CcSEcCtD
Ketamine—Anorexia—Goserelin—breast cancer	0.000268	0.00305	CcSEcCtD
Ketamine—Cystitis noninfective—Epirubicin—breast cancer	0.000265	0.00302	CcSEcCtD
Ketamine—Salivary hypersecretion—Epirubicin—breast cancer	0.000264	0.003	CcSEcCtD
Ketamine—Decreased appetite—Vinblastine—breast cancer	0.000263	0.003	CcSEcCtD
Ketamine—TACR1—lymph node—breast cancer	0.000263	0.0265	CbGeAlD
Ketamine—Hypotension—Goserelin—breast cancer	0.000263	0.00299	CcSEcCtD
Ketamine—Bladder pain—Methotrexate—breast cancer	0.000262	0.00299	CcSEcCtD
Ketamine—Cystitis—Epirubicin—breast cancer	0.000262	0.00298	CcSEcCtD
Ketamine—Arrhythmia—Irinotecan—breast cancer	0.000261	0.00297	CcSEcCtD
Ketamine—Arrhythmia—Mitoxantrone—breast cancer	0.000261	0.00297	CcSEcCtD
Ketamine—Vomiting—Raloxifene—breast cancer	0.00026	0.00295	CcSEcCtD
Ketamine—Vomiting—Idarubicin—breast cancer	0.00026	0.00295	CcSEcCtD
Ketamine—Pain—Vinblastine—breast cancer	0.000259	0.00295	CcSEcCtD
Ketamine—Rash—Idarubicin—breast cancer	0.000257	0.00293	CcSEcCtD
Ketamine—Rash—Raloxifene—breast cancer	0.000257	0.00293	CcSEcCtD
Ketamine—Dermatitis—Idarubicin—breast cancer	0.000257	0.00293	CcSEcCtD
Ketamine—Dermatitis—Raloxifene—breast cancer	0.000257	0.00293	CcSEcCtD
Ketamine—Decreased appetite—Tamoxifen—breast cancer	0.000256	0.00291	CcSEcCtD
Ketamine—Nausea—Letrozole—breast cancer	0.000256	0.00291	CcSEcCtD
Ketamine—Nausea—Anastrozole—breast cancer	0.000256	0.00291	CcSEcCtD
Ketamine—Convulsion—Thiotepa—breast cancer	0.000255	0.00291	CcSEcCtD
Ketamine—Erythema—Mitoxantrone—breast cancer	0.000255	0.0029	CcSEcCtD
Ketamine—Arrhythmia—Gemcitabine—breast cancer	0.000254	0.0029	CcSEcCtD
Ketamine—Anaphylactic shock—Vinorelbine—breast cancer	0.000252	0.00287	CcSEcCtD
Ketamine—Pain—Tamoxifen—breast cancer	0.000252	0.00287	CcSEcCtD
Ketamine—Decreased appetite—Melphalan—breast cancer	0.000251	0.00285	CcSEcCtD
Ketamine—Arrhythmia—Fluorouracil—breast cancer	0.00025	0.00285	CcSEcCtD
Ketamine—Erythema—Gemcitabine—breast cancer	0.000248	0.00282	CcSEcCtD
Ketamine—Pain—Melphalan—breast cancer	0.000247	0.00281	CcSEcCtD
Ketamine—Bladder pain—Epirubicin—breast cancer	0.000245	0.00279	CcSEcCtD
Ketamine—Cystitis noninfective—Doxorubicin—breast cancer	0.000245	0.00279	CcSEcCtD
Ketamine—Decreased appetite—Goserelin—breast cancer	0.000244	0.00278	CcSEcCtD
Ketamine—Salivary hypersecretion—Doxorubicin—breast cancer	0.000244	0.00278	CcSEcCtD
Ketamine—Erythema—Fluorouracil—breast cancer	0.000244	0.00277	CcSEcCtD
Ketamine—PTGS1—nipple—breast cancer	0.000243	0.0245	CbGeAlD
Ketamine—Bradycardia—Paclitaxel—breast cancer	0.000243	0.00276	CcSEcCtD
Ketamine—Nausea—Raloxifene—breast cancer	0.000243	0.00276	CcSEcCtD
Ketamine—Nausea—Idarubicin—breast cancer	0.000243	0.00276	CcSEcCtD
Ketamine—Cystitis—Doxorubicin—breast cancer	0.000243	0.00276	CcSEcCtD
Ketamine—Pain—Goserelin—breast cancer	0.00024	0.00274	CcSEcCtD
Ketamine—Anorexia—Vinorelbine—breast cancer	0.00024	0.00273	CcSEcCtD
Ketamine—Vision blurred—Mitoxantrone—breast cancer	0.00024	0.00273	CcSEcCtD
Ketamine—Hypotension—Vinorelbine—breast cancer	0.000235	0.00268	CcSEcCtD
Ketamine—Vision blurred—Fluorouracil—breast cancer	0.00023	0.00261	CcSEcCtD
Ketamine—Anorexia—Thiotepa—breast cancer	0.000229	0.00261	CcSEcCtD
Ketamine—Bladder pain—Doxorubicin—breast cancer	0.000227	0.00258	CcSEcCtD
Ketamine—Convulsion—Mitoxantrone—breast cancer	0.000221	0.00251	CcSEcCtD
Ketamine—Decreased appetite—Vinorelbine—breast cancer	0.000219	0.00249	CcSEcCtD
Ketamine—Pain—Vinorelbine—breast cancer	0.000215	0.00245	CcSEcCtD
Ketamine—Arrhythmia—Paclitaxel—breast cancer	0.000213	0.00242	CcSEcCtD
Ketamine—OPRM1—endocrine gland—breast cancer	0.000211	0.0212	CbGeAlD
Ketamine—Convulsion—Fluorouracil—breast cancer	0.000211	0.0024	CcSEcCtD
Ketamine—Vomiting—Chlorambucil—breast cancer	0.00021	0.00239	CcSEcCtD
Ketamine—Decreased appetite—Thiotepa—breast cancer	0.000209	0.00238	CcSEcCtD
Ketamine—Anaphylactic shock—Mitoxantrone—breast cancer	0.000208	0.00236	CcSEcCtD
Ketamine—Anaphylactic shock—Irinotecan—breast cancer	0.000208	0.00236	CcSEcCtD
Ketamine—Erythema—Paclitaxel—breast cancer	0.000208	0.00236	CcSEcCtD
Ketamine—Pain—Thiotepa—breast cancer	0.000206	0.00234	CcSEcCtD
Ketamine—Shock—Irinotecan—breast cancer	0.000204	0.00233	CcSEcCtD
Ketamine—Shock—Mitoxantrone—breast cancer	0.000204	0.00233	CcSEcCtD
Ketamine—Anaphylactic shock—Gemcitabine—breast cancer	0.000202	0.0023	CcSEcCtD
Ketamine—Bradycardia—Capecitabine—breast cancer	0.000199	0.00227	CcSEcCtD
Ketamine—Anaphylactic shock—Fluorouracil—breast cancer	0.000199	0.00226	CcSEcCtD
Ketamine—Anorexia—Mitoxantrone—breast cancer	0.000198	0.00225	CcSEcCtD
Ketamine—Anorexia—Irinotecan—breast cancer	0.000198	0.00225	CcSEcCtD
Ketamine—Diplopia—Epirubicin—breast cancer	0.000197	0.00224	CcSEcCtD
Ketamine—Nausea—Chlorambucil—breast cancer	0.000196	0.00224	CcSEcCtD
Ketamine—Vision blurred—Paclitaxel—breast cancer	0.000196	0.00223	CcSEcCtD
Ketamine—Hypotension—Mitoxantrone—breast cancer	0.000194	0.00221	CcSEcCtD
Ketamine—Hypotension—Irinotecan—breast cancer	0.000194	0.00221	CcSEcCtD
Ketamine—Anorexia—Gemcitabine—breast cancer	0.000193	0.0022	CcSEcCtD
Ketamine—Vomiting—Vinblastine—breast cancer	0.000193	0.00219	CcSEcCtD
Ketamine—Anorexia—Fluorouracil—breast cancer	0.00019	0.00216	CcSEcCtD
Ketamine—Hypotension—Gemcitabine—breast cancer	0.000189	0.00215	CcSEcCtD
Ketamine—Vomiting—Tamoxifen—breast cancer	0.000187	0.00213	CcSEcCtD
Ketamine—Hypotension—Fluorouracil—breast cancer	0.000186	0.00212	CcSEcCtD
Ketamine—Rash—Tamoxifen—breast cancer	0.000186	0.00211	CcSEcCtD
Ketamine—Dermatitis—Tamoxifen—breast cancer	0.000185	0.00211	CcSEcCtD
Ketamine—Vomiting—Melphalan—breast cancer	0.000183	0.00209	CcSEcCtD
Ketamine—SLC6A2—female reproductive system—breast cancer	0.000183	0.0184	CbGeAlD
Ketamine—Diplopia—Doxorubicin—breast cancer	0.000182	0.00208	CcSEcCtD
Ketamine—DRD2—pituitary gland—breast cancer	0.000182	0.0183	CbGeAlD
Ketamine—Rash—Melphalan—breast cancer	0.000182	0.00207	CcSEcCtD
Ketamine—Dermatitis—Melphalan—breast cancer	0.000182	0.00207	CcSEcCtD
Ketamine—CYP2C8—endometrium—breast cancer	0.000181	0.0182	CbGeAlD
Ketamine—Decreased appetite—Irinotecan—breast cancer	0.000181	0.00206	CcSEcCtD
Ketamine—Decreased appetite—Mitoxantrone—breast cancer	0.000181	0.00206	CcSEcCtD
Ketamine—Arrhythmia—Docetaxel—breast cancer	0.000181	0.00205	CcSEcCtD
Ketamine—Nausea—Vinblastine—breast cancer	0.00018	0.00205	CcSEcCtD
Ketamine—Convulsion—Paclitaxel—breast cancer	0.00018	0.00205	CcSEcCtD
Ketamine—Vomiting—Goserelin—breast cancer	0.000179	0.00204	CcSEcCtD
Ketamine—SLC6A2—adrenal gland—breast cancer	0.000178	0.0179	CbGeAlD
Ketamine—Pain—Irinotecan—breast cancer	0.000178	0.00202	CcSEcCtD
Ketamine—Pain—Mitoxantrone—breast cancer	0.000178	0.00202	CcSEcCtD
Ketamine—Rash—Goserelin—breast cancer	0.000177	0.00202	CcSEcCtD
Ketamine—Dermatitis—Goserelin—breast cancer	0.000177	0.00202	CcSEcCtD
Ketamine—Erythema—Docetaxel—breast cancer	0.000176	0.002	CcSEcCtD
Ketamine—Decreased appetite—Gemcitabine—breast cancer	0.000176	0.002	CcSEcCtD
Ketamine—Nausea—Tamoxifen—breast cancer	0.000175	0.00199	CcSEcCtD
Ketamine—Arrhythmia—Capecitabine—breast cancer	0.000175	0.00199	CcSEcCtD
Ketamine—Pain—Gemcitabine—breast cancer	0.000173	0.00197	CcSEcCtD
Ketamine—Decreased appetite—Fluorouracil—breast cancer	0.000173	0.00197	CcSEcCtD
Ketamine—CYP2B6—skin of body—breast cancer	0.000172	0.0173	CbGeAlD
Ketamine—Nausea—Melphalan—breast cancer	0.000171	0.00195	CcSEcCtD
Ketamine—Erythema—Capecitabine—breast cancer	0.00017	0.00194	CcSEcCtD
Ketamine—Pain—Fluorouracil—breast cancer	0.00017	0.00194	CcSEcCtD
Ketamine—Anaphylactic shock—Paclitaxel—breast cancer	0.000169	0.00193	CcSEcCtD
Ketamine—Nausea—Goserelin—breast cancer	0.000167	0.0019	CcSEcCtD
Ketamine—Shock—Paclitaxel—breast cancer	0.000167	0.0019	CcSEcCtD
Ketamine—CYP2C8—pituitary gland—breast cancer	0.000164	0.0165	CbGeAlD
Ketamine—PTGS1—epithelium—breast cancer	0.000164	0.0165	CbGeAlD
Ketamine—Anorexia—Paclitaxel—breast cancer	0.000161	0.00184	CcSEcCtD
Ketamine—Vision blurred—Capecitabine—breast cancer	0.000161	0.00183	CcSEcCtD
Ketamine—Vomiting—Vinorelbine—breast cancer	0.00016	0.00182	CcSEcCtD
Ketamine—Rash—Vinorelbine—breast cancer	0.000159	0.00181	CcSEcCtD
Ketamine—Dermatitis—Vinorelbine—breast cancer	0.000159	0.00181	CcSEcCtD
Ketamine—Hypotension—Paclitaxel—breast cancer	0.000158	0.0018	CcSEcCtD
Ketamine—PTGS1—skin of body—breast cancer	0.000156	0.0157	CbGeAlD
Ketamine—SLC6A2—endocrine gland—breast cancer	0.000155	0.0156	CbGeAlD
Ketamine—Vomiting—Thiotepa—breast cancer	0.000153	0.00174	CcSEcCtD
Ketamine—Convulsion—Docetaxel—breast cancer	0.000152	0.00173	CcSEcCtD
Ketamine—Rash—Thiotepa—breast cancer	0.000152	0.00173	CcSEcCtD
Ketamine—Dermatitis—Thiotepa—breast cancer	0.000152	0.00172	CcSEcCtD
Ketamine—CYP2C8—female reproductive system—breast cancer	0.00015	0.0151	CbGeAlD
Ketamine—Nausea—Vinorelbine—breast cancer	0.00015	0.0017	CcSEcCtD
Ketamine—Decreased appetite—Paclitaxel—breast cancer	0.000147	0.00168	CcSEcCtD
Ketamine—PTGS1—endometrium—breast cancer	0.000147	0.0148	CbGeAlD
Ketamine—Pain—Paclitaxel—breast cancer	0.000145	0.00165	CcSEcCtD
Ketamine—Anaphylactic shock—Docetaxel—breast cancer	0.000144	0.00163	CcSEcCtD
Ketamine—Nausea—Thiotepa—breast cancer	0.000143	0.00163	CcSEcCtD
Ketamine—Shock—Docetaxel—breast cancer	0.000141	0.00161	CcSEcCtD
Ketamine—DRD2—endocrine gland—breast cancer	0.000141	0.0142	CbGeAlD
Ketamine—Bradycardia—Epirubicin—breast cancer	0.000139	0.00158	CcSEcCtD
Ketamine—Anorexia—Docetaxel—breast cancer	0.000137	0.00156	CcSEcCtD
Ketamine—Shock—Capecitabine—breast cancer	0.000137	0.00156	CcSEcCtD
Ketamine—PTGS1—uterus—breast cancer	0.000135	0.0136	CbGeAlD
Ketamine—CYP2B6—female reproductive system—breast cancer	0.000135	0.0135	CbGeAlD
Ketamine—Hypotension—Docetaxel—breast cancer	0.000134	0.00153	CcSEcCtD
Ketamine—CYP2C9—female reproductive system—breast cancer	0.000133	0.0134	CbGeAlD
Ketamine—PTGS1—pituitary gland—breast cancer	0.000133	0.0134	CbGeAlD
Ketamine—Anorexia—Capecitabine—breast cancer	0.000133	0.00151	CcSEcCtD
Ketamine—PTGS1—adipose tissue—breast cancer	0.000132	0.0133	CbGeAlD
Ketamine—Vomiting—Mitoxantrone—breast cancer	0.000132	0.0015	CcSEcCtD
Ketamine—Vomiting—Irinotecan—breast cancer	0.000132	0.0015	CcSEcCtD
Ketamine—CYP2B6—adrenal gland—breast cancer	0.000131	0.0132	CbGeAlD
Ketamine—Rash—Mitoxantrone—breast cancer	0.000131	0.00149	CcSEcCtD
Ketamine—Rash—Irinotecan—breast cancer	0.000131	0.00149	CcSEcCtD
Ketamine—Dermatitis—Mitoxantrone—breast cancer	0.000131	0.00149	CcSEcCtD
Ketamine—Dermatitis—Irinotecan—breast cancer	0.000131	0.00149	CcSEcCtD
Ketamine—Hypotension—Capecitabine—breast cancer	0.00013	0.00148	CcSEcCtD
Ketamine—Vomiting—Gemcitabine—breast cancer	0.000129	0.00146	CcSEcCtD
Ketamine—Bradycardia—Doxorubicin—breast cancer	0.000128	0.00146	CcSEcCtD
Ketamine—Rash—Gemcitabine—breast cancer	0.000128	0.00145	CcSEcCtD
Ketamine—Dermatitis—Gemcitabine—breast cancer	0.000127	0.00145	CcSEcCtD
Ketamine—CYP2C8—endocrine gland—breast cancer	0.000127	0.0128	CbGeAlD
Ketamine—Erythema—Methotrexate—breast cancer	0.000127	0.00144	CcSEcCtD
Ketamine—Vomiting—Fluorouracil—breast cancer	0.000126	0.00144	CcSEcCtD
Ketamine—Rash—Fluorouracil—breast cancer	0.000125	0.00143	CcSEcCtD
Ketamine—Dermatitis—Fluorouracil—breast cancer	0.000125	0.00143	CcSEcCtD
Ketamine—Decreased appetite—Docetaxel—breast cancer	0.000125	0.00142	CcSEcCtD
Ketamine—Nausea—Irinotecan—breast cancer	0.000123	0.0014	CcSEcCtD
Ketamine—Nausea—Mitoxantrone—breast cancer	0.000123	0.0014	CcSEcCtD
Ketamine—Pain—Docetaxel—breast cancer	0.000123	0.0014	CcSEcCtD
Ketamine—Arrhythmia—Epirubicin—breast cancer	0.000122	0.00139	CcSEcCtD
Ketamine—PTGS1—female reproductive system—breast cancer	0.000122	0.0122	CbGeAlD
Ketamine—Decreased appetite—Capecitabine—breast cancer	0.000121	0.00138	CcSEcCtD
Ketamine—Nausea—Gemcitabine—breast cancer	0.00012	0.00137	CcSEcCtD
Ketamine—Vision blurred—Methotrexate—breast cancer	0.00012	0.00136	CcSEcCtD
Ketamine—Pain—Capecitabine—breast cancer	0.000119	0.00135	CcSEcCtD
Ketamine—PTGS1—adrenal gland—breast cancer	0.000119	0.0119	CbGeAlD
Ketamine—ABCB1—embryo—breast cancer	0.000119	0.0119	CbGeAlD
Ketamine—Erythema—Epirubicin—breast cancer	0.000119	0.00135	CcSEcCtD
Ketamine—Nausea—Fluorouracil—breast cancer	0.000118	0.00134	CcSEcCtD
Ketamine—CYP2B6—endocrine gland—breast cancer	0.000114	0.0115	CbGeAlD
Ketamine—CYP2C9—endocrine gland—breast cancer	0.000113	0.0113	CbGeAlD
Ketamine—Arrhythmia—Doxorubicin—breast cancer	0.000113	0.00128	CcSEcCtD
Ketamine—Vision blurred—Epirubicin—breast cancer	0.000112	0.00127	CcSEcCtD
Ketamine—PTGS1—female gonad—breast cancer	0.000111	0.0111	CbGeAlD
Ketamine—Convulsion—Methotrexate—breast cancer	0.00011	0.00125	CcSEcCtD
Ketamine—Erythema—Doxorubicin—breast cancer	0.00011	0.00125	CcSEcCtD
Ketamine—Vomiting—Paclitaxel—breast cancer	0.000108	0.00123	CcSEcCtD
Ketamine—SLC6A2—lymph node—breast cancer	0.000107	0.0108	CbGeAlD
Ketamine—Rash—Paclitaxel—breast cancer	0.000107	0.00122	CcSEcCtD
Ketamine—Dermatitis—Paclitaxel—breast cancer	0.000107	0.00121	CcSEcCtD
Ketamine—Anaphylactic shock—Methotrexate—breast cancer	0.000103	0.00118	CcSEcCtD
Ketamine—Vision blurred—Doxorubicin—breast cancer	0.000103	0.00118	CcSEcCtD
Ketamine—PTGS1—endocrine gland—breast cancer	0.000103	0.0104	CbGeAlD
Ketamine—Convulsion—Epirubicin—breast cancer	0.000103	0.00117	CcSEcCtD
Ketamine—CYP3A4—female reproductive system—breast cancer	0.000102	0.0102	CbGeAlD
Ketamine—Nausea—Paclitaxel—breast cancer	0.000101	0.00115	CcSEcCtD
Ketamine—Anorexia—Methotrexate—breast cancer	9.86e-05	0.00112	CcSEcCtD
Ketamine—ABCB1—epithelium—breast cancer	9.69e-05	0.00974	CbGeAlD
Ketamine—Anaphylactic shock—Epirubicin—breast cancer	9.68e-05	0.0011	CcSEcCtD
Ketamine—Hypotension—Methotrexate—breast cancer	9.67e-05	0.0011	CcSEcCtD
Ketamine—Shock—Epirubicin—breast cancer	9.53e-05	0.00108	CcSEcCtD
Ketamine—Convulsion—Doxorubicin—breast cancer	9.51e-05	0.00108	CcSEcCtD
Ketamine—Anorexia—Epirubicin—breast cancer	9.23e-05	0.00105	CcSEcCtD
Ketamine—Vomiting—Docetaxel—breast cancer	9.13e-05	0.00104	CcSEcCtD
Ketamine—Rash—Docetaxel—breast cancer	9.05e-05	0.00103	CcSEcCtD
Ketamine—Hypotension—Epirubicin—breast cancer	9.05e-05	0.00103	CcSEcCtD
Ketamine—Dermatitis—Docetaxel—breast cancer	9.05e-05	0.00103	CcSEcCtD
Ketamine—Decreased appetite—Methotrexate—breast cancer	9e-05	0.00102	CcSEcCtD
Ketamine—Anaphylactic shock—Doxorubicin—breast cancer	8.96e-05	0.00102	CcSEcCtD
Ketamine—Pain—Methotrexate—breast cancer	8.85e-05	0.00101	CcSEcCtD
Ketamine—Vomiting—Capecitabine—breast cancer	8.84e-05	0.00101	CcSEcCtD
Ketamine—Shock—Doxorubicin—breast cancer	8.82e-05	0.001	CcSEcCtD
Ketamine—Rash—Capecitabine—breast cancer	8.77e-05	0.000998	CcSEcCtD
Ketamine—Dermatitis—Capecitabine—breast cancer	8.76e-05	0.000997	CcSEcCtD
Ketamine—ABCB1—endometrium—breast cancer	8.69e-05	0.00874	CbGeAlD
Ketamine—CYP3A4—endocrine gland—breast cancer	8.6e-05	0.00865	CbGeAlD
Ketamine—Anorexia—Doxorubicin—breast cancer	8.54e-05	0.000972	CcSEcCtD
Ketamine—Nausea—Docetaxel—breast cancer	8.53e-05	0.000971	CcSEcCtD
Ketamine—Decreased appetite—Epirubicin—breast cancer	8.42e-05	0.000958	CcSEcCtD
Ketamine—Hypotension—Doxorubicin—breast cancer	8.37e-05	0.000953	CcSEcCtD
Ketamine—Pain—Epirubicin—breast cancer	8.28e-05	0.000943	CcSEcCtD
Ketamine—Nausea—Capecitabine—breast cancer	8.26e-05	0.00094	CcSEcCtD
Ketamine—ABCB1—uterus—breast cancer	8.01e-05	0.00805	CbGeAlD
Ketamine—ABCB1—pituitary gland—breast cancer	7.86e-05	0.00791	CbGeAlD
Ketamine—ABCB1—adipose tissue—breast cancer	7.83e-05	0.00787	CbGeAlD
Ketamine—Decreased appetite—Doxorubicin—breast cancer	7.79e-05	0.000887	CcSEcCtD
Ketamine—Pain—Doxorubicin—breast cancer	7.66e-05	0.000872	CcSEcCtD
Ketamine—ABCB1—female reproductive system—breast cancer	7.2e-05	0.00724	CbGeAlD
Ketamine—PTGS1—lymph node—breast cancer	7.12e-05	0.00716	CbGeAlD
Ketamine—ABCB1—adrenal gland—breast cancer	7.02e-05	0.00706	CbGeAlD
Ketamine—ABCB1—bone marrow—breast cancer	6.79e-05	0.00683	CbGeAlD
Ketamine—Vomiting—Methotrexate—breast cancer	6.58e-05	0.000749	CcSEcCtD
Ketamine—ABCB1—female gonad—breast cancer	6.55e-05	0.00659	CbGeAlD
Ketamine—Rash—Methotrexate—breast cancer	6.53e-05	0.000743	CcSEcCtD
Ketamine—Dermatitis—Methotrexate—breast cancer	6.52e-05	0.000742	CcSEcCtD
Ketamine—Vomiting—Epirubicin—breast cancer	6.16e-05	0.000701	CcSEcCtD
Ketamine—Nausea—Methotrexate—breast cancer	6.15e-05	0.0007	CcSEcCtD
Ketamine—Rash—Epirubicin—breast cancer	6.11e-05	0.000695	CcSEcCtD
Ketamine—Dermatitis—Epirubicin—breast cancer	6.1e-05	0.000694	CcSEcCtD
Ketamine—ABCB1—endocrine gland—breast cancer	6.09e-05	0.00613	CbGeAlD
Ketamine—Nausea—Epirubicin—breast cancer	5.75e-05	0.000655	CcSEcCtD
Ketamine—Vomiting—Doxorubicin—breast cancer	5.7e-05	0.000649	CcSEcCtD
Ketamine—Rash—Doxorubicin—breast cancer	5.65e-05	0.000643	CcSEcCtD
Ketamine—Dermatitis—Doxorubicin—breast cancer	5.64e-05	0.000643	CcSEcCtD
Ketamine—Nausea—Doxorubicin—breast cancer	5.32e-05	0.000606	CcSEcCtD
Ketamine—ABCB1—lymph node—breast cancer	4.21e-05	0.00423	CbGeAlD
Ketamine—OPRD1—Signaling Pathways—SRC—breast cancer	2.71e-06	2.28e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—breast cancer	2.71e-06	2.27e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NOS3—breast cancer	2.71e-06	2.27e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MED12—breast cancer	2.71e-06	2.27e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—DPYD—breast cancer	2.71e-06	2.27e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—COMT—breast cancer	2.71e-06	2.27e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KDR—breast cancer	2.7e-06	2.26e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTP1—breast cancer	2.69e-06	2.26e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP1A1—breast cancer	2.69e-06	2.26e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ERCC2—breast cancer	2.67e-06	2.24e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALDOA—breast cancer	2.67e-06	2.23e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCND1—breast cancer	2.66e-06	2.23e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HMOX1—breast cancer	2.66e-06	2.23e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—JUN—breast cancer	2.65e-06	2.22e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ITPR1—breast cancer	2.65e-06	2.22e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—breast cancer	2.64e-06	2.22e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CTNNB1—breast cancer	2.63e-06	2.21e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ESR1—breast cancer	2.63e-06	2.2e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STAT3—breast cancer	2.62e-06	2.19e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FN1—breast cancer	2.59e-06	2.17e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	2.59e-06	2.17e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NCOA3—breast cancer	2.59e-06	2.17e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—breast cancer	2.58e-06	2.16e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MDM2—breast cancer	2.58e-06	2.16e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1A—breast cancer	2.57e-06	2.16e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RAF1—breast cancer	2.57e-06	2.15e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC2A2—breast cancer	2.57e-06	2.15e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTEN—breast cancer	2.57e-06	2.15e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NFKBIA—breast cancer	2.56e-06	2.15e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RELA—breast cancer	2.56e-06	2.15e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.55e-06	2.14e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ERBB2—breast cancer	2.54e-06	2.13e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOTCH1—breast cancer	2.54e-06	2.13e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—COMT—breast cancer	2.53e-06	2.12e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CPT1A—breast cancer	2.52e-06	2.11e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MTR—breast cancer	2.52e-06	2.11e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCG2—breast cancer	2.52e-06	2.11e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTP1—breast cancer	2.52e-06	2.11e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—MTHFR—breast cancer	2.51e-06	2.1e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK8—breast cancer	2.51e-06	2.1e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CB—breast cancer	2.51e-06	2.1e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MTOR—breast cancer	2.51e-06	2.1e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—TYMS—breast cancer	2.5e-06	2.1e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AKT1—breast cancer	2.5e-06	2.1e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CB—breast cancer	2.5e-06	2.1e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK3—breast cancer	2.5e-06	2.1e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CG—breast cancer	2.49e-06	2.09e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APC—breast cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KIT—breast cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CG—breast cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HMOX1—breast cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—breast cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ITPR1—breast cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NCOR1—breast cancer	2.48e-06	2.07e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PLA2G4A—breast cancer	2.48e-06	2.07e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTM1—breast cancer	2.48e-06	2.07e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HPGDS—breast cancer	2.47e-06	2.07e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGF—breast cancer	2.45e-06	2.06e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HBA1—breast cancer	2.45e-06	2.06e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—breast cancer	2.43e-06	2.04e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TGFB1—breast cancer	2.43e-06	2.03e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL8—breast cancer	2.41e-06	2.02e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HRAS—breast cancer	2.4e-06	2.01e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTT1—breast cancer	2.39e-06	2.01e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ACHE—breast cancer	2.39e-06	2.01e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ABCB1—breast cancer	2.38e-06	2e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SRC—breast cancer	2.38e-06	1.99e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—breast cancer	2.38e-06	1.99e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK3—breast cancer	2.38e-06	1.99e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GPX1—breast cancer	2.37e-06	1.99e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1B—breast cancer	2.36e-06	1.97e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP1A1—breast cancer	2.35e-06	1.97e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TYMS—breast cancer	2.34e-06	1.96e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BRAF—breast cancer	2.33e-06	1.96e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AKT1—breast cancer	2.33e-06	1.95e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ERCC2—breast cancer	2.33e-06	1.95e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—breast cancer	2.32e-06	1.94e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CAV1—breast cancer	2.32e-06	1.94e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.31e-06	1.94e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTM1—breast cancer	2.31e-06	1.94e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NCOR1—breast cancer	2.31e-06	1.94e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CASP3—breast cancer	2.31e-06	1.94e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—breast cancer	2.31e-06	1.93e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT3—breast cancer	2.3e-06	1.92e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—breast cancer	2.29e-06	1.92e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1—breast cancer	2.27e-06	1.91e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT2—breast cancer	2.27e-06	1.9e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP17A1—breast cancer	2.27e-06	1.9e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—breast cancer	2.26e-06	1.9e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KRAS—breast cancer	2.25e-06	1.88e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCND1—breast cancer	2.25e-06	1.88e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ENO1—breast cancer	2.24e-06	1.88e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS1—breast cancer	2.24e-06	1.88e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—JUN—breast cancer	2.24e-06	1.88e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CTNNB1—breast cancer	2.23e-06	1.87e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GPX1—breast cancer	2.21e-06	1.86e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.21e-06	1.85e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2D6—breast cancer	2.2e-06	1.84e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK3—breast cancer	2.19e-06	1.84e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP1A1—breast cancer	2.19e-06	1.84e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CD—breast cancer	2.19e-06	1.84e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—MTHFR—breast cancer	2.19e-06	1.83e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CD—breast cancer	2.18e-06	1.83e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—breast cancer	2.18e-06	1.83e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ERCC2—breast cancer	2.17e-06	1.82e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1A—breast cancer	2.17e-06	1.82e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTEN—breast cancer	2.17e-06	1.82e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTEN—breast cancer	2.16e-06	1.81e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ALB—breast cancer	2.16e-06	1.81e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	2.16e-06	1.81e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NCOA2—breast cancer	2.16e-06	1.81e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SERPINE1—breast cancer	2.16e-06	1.81e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—KRAS—breast cancer	2.14e-06	1.79e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—breast cancer	2.13e-06	1.79e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TGFB1—breast cancer	2.13e-06	1.78e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK8—breast cancer	2.12e-06	1.78e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AKT1—breast cancer	2.12e-06	1.77e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CG—breast cancer	2.11e-06	1.77e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—FASN—breast cancer	2.09e-06	1.76e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—breast cancer	2.09e-06	1.75e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—BCHE—breast cancer	2.09e-06	1.75e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NOS3—breast cancer	2.07e-06	1.73e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PIK3CA—breast cancer	2.06e-06	1.73e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOS3—breast cancer	2.06e-06	1.73e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC5A5—breast cancer	2.06e-06	1.73e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MTHFR—breast cancer	2.04e-06	1.71e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CAV1—breast cancer	2.02e-06	1.69e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SRC—breast cancer	2.01e-06	1.69e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—breast cancer	2e-06	1.67e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NQO1—breast cancer	1.99e-06	1.67e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.99e-06	1.67e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KRAS—breast cancer	1.97e-06	1.65e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CA—breast cancer	1.96e-06	1.65e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—breast cancer	1.96e-06	1.64e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MDM2—breast cancer	1.96e-06	1.64e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RAF1—breast cancer	1.95e-06	1.63e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT3—breast cancer	1.94e-06	1.63e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RELA—breast cancer	1.94e-06	1.63e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ERBB2—breast cancer	1.93e-06	1.62e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HRAS—breast cancer	1.91e-06	1.6e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CB—breast cancer	1.91e-06	1.6e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.91e-06	1.6e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CB—breast cancer	1.9e-06	1.59e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MTOR—breast cancer	1.9e-06	1.59e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—breast cancer	1.89e-06	1.59e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CAV1—breast cancer	1.89e-06	1.58e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.87e-06	1.57e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CD—breast cancer	1.85e-06	1.55e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK3—breast cancer	1.85e-06	1.55e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CG—breast cancer	1.84e-06	1.54e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ALB—breast cancer	1.83e-06	1.53e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—breast cancer	1.83e-06	1.53e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL8—breast cancer	1.83e-06	1.53e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NCOA1—breast cancer	1.82e-06	1.53e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HRAS—breast cancer	1.82e-06	1.52e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CA—breast cancer	1.81e-06	1.52e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—breast cancer	1.8e-06	1.51e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.8e-06	1.51e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TGFB1—breast cancer	1.8e-06	1.51e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—STK11—breast cancer	1.79e-06	1.5e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.79e-06	1.5e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1B—breast cancer	1.79e-06	1.5e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AKT1—breast cancer	1.77e-06	1.48e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—breast cancer	1.76e-06	1.48e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—breast cancer	1.75e-06	1.47e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NOS3—breast cancer	1.75e-06	1.47e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CASP3—breast cancer	1.75e-06	1.47e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—breast cancer	1.75e-06	1.46e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—breast cancer	1.74e-06	1.46e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CG—breast cancer	1.72e-06	1.44e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCND1—breast cancer	1.7e-06	1.43e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JUN—breast cancer	1.7e-06	1.42e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKT1—breast cancer	1.69e-06	1.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CTNNB1—breast cancer	1.69e-06	1.41e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HRAS—breast cancer	1.68e-06	1.4e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—COMT—breast cancer	1.67e-06	1.4e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KRAS—breast cancer	1.67e-06	1.4e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTP1—breast cancer	1.66e-06	1.39e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—breast cancer	1.65e-06	1.39e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTEN—breast cancer	1.65e-06	1.38e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.65e-06	1.38e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTEN—breast cancer	1.64e-06	1.38e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HMOX1—breast cancer	1.64e-06	1.37e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ITPR1—breast cancer	1.63e-06	1.37e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CB—breast cancer	1.62e-06	1.35e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CD—breast cancer	1.62e-06	1.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK8—breast cancer	1.61e-06	1.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AKT1—breast cancer	1.6e-06	1.34e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—breast cancer	1.6e-06	1.34e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—breast cancer	1.6e-06	1.34e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ALB—breast cancer	1.6e-06	1.34e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCB1—breast cancer	1.57e-06	1.32e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TYMS—breast cancer	1.54e-06	1.29e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CA—breast cancer	1.53e-06	1.28e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NOS3—breast cancer	1.53e-06	1.28e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CA—breast cancer	1.53e-06	1.28e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTM1—breast cancer	1.53e-06	1.28e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NCOR1—breast cancer	1.53e-06	1.28e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.53e-06	1.28e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SRC—breast cancer	1.52e-06	1.28e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CD—breast cancer	1.51e-06	1.27e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ALB—breast cancer	1.49e-06	1.25e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—breast cancer	1.48e-06	1.24e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—breast cancer	1.48e-06	1.24e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT1—breast cancer	1.48e-06	1.24e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT3—breast cancer	1.47e-06	1.23e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GPX1—breast cancer	1.46e-06	1.22e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.45e-06	1.21e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ERCC2—breast cancer	1.43e-06	1.2e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NOS3—breast cancer	1.43e-06	1.19e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HRAS—breast cancer	1.42e-06	1.19e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CB—breast cancer	1.41e-06	1.18e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK3—breast cancer	1.4e-06	1.18e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTEN—breast cancer	1.4e-06	1.17e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—breast cancer	1.4e-06	1.17e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—breast cancer	1.37e-06	1.14e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TGFB1—breast cancer	1.36e-06	1.14e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—breast cancer	1.36e-06	1.14e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MTHFR—breast cancer	1.35e-06	1.13e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—breast cancer	1.34e-06	1.12e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CB—breast cancer	1.32e-06	1.1e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—breast cancer	1.3e-06	1.09e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KRAS—breast cancer	1.26e-06	1.06e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT1—breast cancer	1.25e-06	1.05e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AKT1—breast cancer	1.25e-06	1.04e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CAV1—breast cancer	1.24e-06	1.04e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTEN—breast cancer	1.22e-06	1.02e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CA—breast cancer	1.16e-06	9.76e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.16e-06	9.72e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTEN—breast cancer	1.14e-06	9.53e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.13e-06	9.49e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—breast cancer	1.12e-06	9.4e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HRAS—breast cancer	1.07e-06	8.99e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—breast cancer	1.03e-06	8.61e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CD—breast cancer	9.95e-07	8.34e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CA—breast cancer	9.85e-07	8.26e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALB—breast cancer	9.83e-07	8.24e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AKT1—breast cancer	9.51e-07	7.97e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT1—breast cancer	9.47e-07	7.94e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NOS3—breast cancer	9.4e-07	7.88e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CB—breast cancer	8.68e-07	7.27e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—breast cancer	8.6e-07	7.21e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CA—breast cancer	8.59e-07	7.2e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AKT1—breast cancer	8.05e-07	6.75e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CA—breast cancer	8.02e-07	6.72e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTEN—breast cancer	7.5e-07	6.28e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKT1—breast cancer	7.01e-07	5.88e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKT1—breast cancer	6.55e-07	5.49e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CA—breast cancer	5.29e-07	4.43e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKT1—breast cancer	4.32e-07	3.62e-06	CbGpPWpGaD
